Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


Articles published in Anticancer Res

Retrieve available abstracts of 168 articles:
HTML format
Text format



Single Articles


    November 2017
  1. MATSUI A, Tatibana A, Suzuki N, Hirata M, et al
    Evaluation of Efficacy and Safety of Upfront Weekly Nanoparticle Albumin-bound Paclitaxel for HER2-negative Breast Cancer.
    Anticancer Res. 2017;37:6481-6488.
    PubMed     Text format     Abstract available


  2. SHEIKH IA, Jiffri EH, Kamal MA, Ashraf GM, et al
    Lactoperoxidase, an Antimicrobial Milk Protein, as a Potential Activator of Carcinogenic Heterocyclic Amines in Breast Cancer.
    Anticancer Res. 2017;37:6415-6420.
    PubMed     Text format     Abstract available


  3. SHEIKH IA, Beg MA, Yasir M
    Molecular Interactions of Carcinogenic Aromatic Amines, 4-Aminobiphenyl and 4,4'-Diaminobiphenyl, with Lactoperoxidase - Insight to Breast Cancer.
    Anticancer Res. 2017;37:6245-6249.
    PubMed     Text format     Abstract available


  4. JEON D, Kim H, Nam K, Oh S, et al
    Cytotoxic Effect of Nano-SiO2 in Human Breast Cancer Cells via Modulation of EGFR Signaling Cascades.
    Anticancer Res. 2017;37:6189-6197.
    PubMed     Text format     Abstract available


  5. WAKIMOTO R, Ono M, Takeshima M, Higuchi T, et al
    Differential Anticancer Activity of Pterostilbene Against Three Subtypes of Human Breast Cancer Cells.
    Anticancer Res. 2017;37:6153-6159.
    PubMed     Text format     Abstract available


  6. DU J, Sun Y, Lu YY, Lau E, et al
    Berberine and Evodiamine Act Synergistically Against Human Breast Cancer MCF-7 Cells by Inducing Cell Cycle Arrest and Apoptosis.
    Anticancer Res. 2017;37:6141-6151.
    PubMed     Text format     Abstract available


    October 2017
  7. SHOJI F, Yamashita N, Inoue Y, Kozuma Y, et al
    Surgical Resection and Outcome of Synchronous and Metachronous Primary Lung Cancer in Breast Cancer Patients.
    Anticancer Res. 2017;37:5871-5876.
    PubMed     Text format     Abstract available


  8. KARMAKAR MK, Samy W, Lee A, Li JW, et al
    Survival Analysis of Patients with Breast Cancer Undergoing a Modified Radical Mastectomy With or Without a Thoracic Paravertebral Block: a 5-Year Follow-up of a Randomized Controlled Trial.
    Anticancer Res. 2017;37:5813-5820.
    PubMed     Text format     Abstract available


  9. HE K, Wang X, Guan X, Yu Q, et al
    Vinorelbine Plus Gemcitabine or Cisplatin as First-line Treatment of HER2-negative Advanced Breast Cancer.
    Anticancer Res. 2017;37:5647-5653.
    PubMed     Text format     Abstract available


  10. KASHIWAGI S, Asano Y, Goto W, Takada K, et al
    Using TILs to Predict Therapeutic Effect of Chemotherapy (Pertuzumab, Trastuzumab, Docetaxel) on HER2-positive Breast Cancer.
    Anticancer Res. 2017;37:5623-5630.
    PubMed     Text format     Abstract available


  11. CHU QD, Zhou M, Medeiros KL, Peddi P, et al
    Impact of CALGB 9343 Trial and Sociodemographic Variation on Patterns of Adjuvant Radiation Therapy Practice for Elderly Women (>/=70 Years) with Stage I, Estrogen Receptor-positive Breast Cancer: Analysis of the National Cancer Data Base.
    Anticancer Res. 2017;37:5585-5594.
    PubMed     Text format     Abstract available


  12. PHAM DH, Kim JS, Kim SK, Shin DJ, et al
    Effects of ADAM10 and ADAM17 Inhibitors on Natural Killer Cell Expansion and Antibody-dependent Cellular Cytotoxicity Against Breast Cancer Cells In Vitro.
    Anticancer Res. 2017;37:5507-5513.
    PubMed     Text format     Abstract available


  13. BOBIN-DUBIGEON C, Chauvin A, Brillaud-Meflah V, Boiffard F, et al
    Liver X Receptor (LXR)-regulated Genes of Cholesterol Trafficking and Breast Cancer Severity.
    Anticancer Res. 2017;37:5495-5498.
    PubMed     Text format     Abstract available


  14. CALIS IU, Cosan DT, Mutlu F
    Effects of S1P1 and S1P3 in ER+ and ER- Breast Cancer Cells.
    Anticancer Res. 2017;37:5469-5475.
    PubMed     Text format     Abstract available


  15. GIGLI S, Amabile MI, DI Pastena F, DE Luca A, et al
    Lipofilling Outcomes Mimicking Breast Cancer Recurrence: Case Report and Update of the Literature.
    Anticancer Res. 2017;37:5395-5398.
    PubMed     Text format     Abstract available


  16. HARUNA F, Lipsett A, Marignol L
    Topical Management of Acute Radiation Dermatitis in Breast Cancer Patients: A Systematic Review and Meta-Analysis.
    Anticancer Res. 2017;37:5343-5353.
    PubMed     Text format     Abstract available


  17. GLASSMAN D, Hignett S, Rehman S, Linforth R, et al
    Adjuvant Endocrine Therapy for Hormone-positive Breast Cancer, Focusing on Ovarian Suppression and Extended Treatment: An Update.
    Anticancer Res. 2017;37:5329-5341.
    PubMed     Text format     Abstract available


  18. GRZEGRZOLKA J, Wojtyra P, Biala M, Piotrowska A, et al
    Correlation Between Expression of Twist and Podoplanin in Ductal Breast Carcinoma.
    Anticancer Res. 2017;37:5485-5493.
    PubMed     Text format     Abstract available


    September 2017
  19. KRAMMER J, Stepniewski K, Kaiser CG, Brade J, et al
    Value of Additional Digital Breast Tomosynthesis for Preoperative Staging of Breast Cancer in Dense Breasts.
    Anticancer Res. 2017;37:5255-5261.
    PubMed     Text format     Abstract available


  20. YAMASHITA N, Tokunaga E, Yamamoto H, Shimizu C, et al
    The Local Recurrence of Breast Cancer with Squamous Metaplasia and Obvious Histological Heterogeneity.
    Anticancer Res. 2017;37:5249-5254.
    PubMed     Text format     Abstract available


  21. RICCIARDI E, Tomao F, Aletti G, Bazzurini L, et al
    Risk-reducing Salpingo-Oophorectomy in Women at Higher Risk of Ovarian and Breast Cancer: A Single Institution Prospective Series.
    Anticancer Res. 2017;37:5241-5248.
    PubMed     Text format     Abstract available


  22. WAKAHARA M, Sakabe T, Kubouchi Y, Hosoya K, et al
    Subcellular Localization of Maspin Correlates with Histone Deacetylase 1 Expression in Human Breast Cancer.
    Anticancer Res. 2017;37:5071-5077.
    PubMed     Text format     Abstract available


  23. PAN E, Tung L, Ragab O, Morocco E, et al
    Inflammatory Breast Cancer Outcomes in a Contemporary Series.
    Anticancer Res. 2017;37:5057-5063.
    PubMed     Text format     Abstract available


  24. CHOU AK, Hsiao CL, Shih TC, Wang HC, et al
    The Contribution of Matrix Metalloproteinase-7 Promoter Genotypes in Breast Cancer in Taiwan.
    Anticancer Res. 2017;37:4973-4977.
    PubMed     Text format     Abstract available


  25. KORASHY HM, Maayah ZH, Al Anazi FE, Alsaad AM, et al
    Sunitinib Inhibits Breast Cancer Cell Proliferation by Inducing Apoptosis, Cell-cycle Arrest and DNA Repair While Inhibiting NF-kappaB Signaling Pathways.
    Anticancer Res. 2017;37:4899-4909.
    PubMed     Text format     Abstract available


  26. TIMMER M, Werner JM, Rohn G, Ortmann M, et al
    Discordance and Conversion Rates of Progesterone-, Estrogen-, and HER2/neu-Receptor Status in Primary Breast Cancer and Brain Metastasis Mainly Triggered by Hormone Therapy.
    Anticancer Res. 2017;37:4859-4865.
    PubMed     Text format     Abstract available


  27. FANG QI, Wang X, Luo G, Yu M, et al
    Increased CXCL8 Expression Is Negatively Correlated with the Overall Survival of Patients with ER-Negative Breast Cancer.
    Anticancer Res. 2017;37:4845-4852.
    PubMed     Text format     Abstract available


  28. KIM D, Radin D, Leonardi D
    Probing the Molecular Mechanisms Governing the Oncolytic Activity of Paeonia suffruticosa on Triple-negative Breast Cancer Cells In Vitro.
    Anticancer Res. 2017;37:4813-4819.
    PubMed     Text format     Abstract available


  29. KUBAN-JANKOWSKA A, Sahu KK, Gorska-Ponikowska M, Tuszynski JA, et al
    Inhibitory Activity of Iron Chelators ATA and DFO on MCF-7 Breast Cancer Cells and Phosphatases PTP1B and SHP2.
    Anticancer Res. 2017;37:4799-4806.
    PubMed     Text format     Abstract available


  30. ISHITOBI M, Fukui R, Hashimoto Y, Kittaka N, et al
    Safety for Repeat Lumpectomy Without Radiotherapy for Ipsilateral Breast Tumor Recurrence.
    Anticancer Res. 2017;37:5293-5299.
    PubMed     Text format     Abstract available


  31. EICHLER C, Abrar S, Puppe J, Arndt M, et al
    Detection of Ductal Carcinoma In Situ by Ultrasound and Mammography: Size-dependent Inaccuracy.
    Anticancer Res. 2017;37:5065-5070.
    PubMed     Text format     Abstract available


  32. FUJII T, Yanai K, Tokuda S, Nakazawa Y, et al
    Clinicopathological Features of Ductal Carcinoma In Situ from 18F-FDG-PET Findings.
    Anticancer Res. 2017;37:5053-5056.
    PubMed     Text format     Abstract available


  33. UEHARA S, Saito K, Asami H, Ohta Y, et al
    Role of ARHGAP24 in ADP Ribosylation Factor 6 (ARF6)-dependent Pseudopod Formation in Human Breast Carcinoma Cells.
    Anticancer Res. 2017;37:4837-4844.
    PubMed     Text format     Abstract available


    August 2017
  34. ZHOU B, Xu L, Ye J, Xin L, et al
    The Prognostic Value of the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging System in HER2-Enriched Subtype Breast Cancer, a Retrospective Analysis.
    Anticancer Res. 2017;37:4615-4621.
    PubMed     Text format     Abstract available


  35. LANG Z, Wu Y, Li C, Li X, et al
    Multifocal and Multicentric Breast Carcinoma: A Significantly More Aggressive Tumor than Unifocal Breast Cancer.
    Anticancer Res. 2017;37:4593-4598.
    PubMed     Text format     Abstract available


  36. QIN T, Zeng YD, Lu Q, Zhang X, et al
    Nomogram Model of LNR Predicts Survival in Premenopausal Patients with Node-positive Luminal Breast Cancer.
    Anticancer Res. 2017;37:4575-4586.
    PubMed     Text format     Abstract available


  37. YE J, Wang W, Xin L, Owen S, et al
    The Clinicopathological Factors Associated with Disease Progression in Luminal A Breast Cancer and Characteristics of Metastasis: A Retrospective Study from A Single Center in China.
    Anticancer Res. 2017;37:4549-4556.
    PubMed     Text format     Abstract available


  38. ZENG Y, Li Q, Qin T, Li S, et al
    Impact of a 21-Gene Recurrence Score Test on the Choice of Adjuvant Chemotherapy for Hormone Receptor-positive Early-stage Breast Cancer: A Prospective Study.
    Anticancer Res. 2017;37:4539-4547.
    PubMed     Text format     Abstract available


  39. MALIK MFA, Riaz SK, Waqar SH, Haq F, et al
    Role of Plexin B1 in a Breast Cancer Cohort of Pakistani Patients and its Contribution Towards Cancer Metastasis as Indicated by an In Vitro Model.
    Anticancer Res. 2017;37:4483-4488.
    PubMed     Text format     Abstract available


  40. LI Z, Peng Z, Gu S, Zheng J, et al
    Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
    Anticancer Res. 2017;37:4455-4468.
    PubMed     Text format     Abstract available


  41. RIAZ SK, Ye L, Sahar NE, Aman D, et al
    Transcriptional Profiling of Sonic Hedgehog in a Prospective Cohort of Breast Cancer in a Pakistani Population.
    Anticancer Res. 2017;37:4449-4454.
    PubMed     Text format     Abstract available


  42. WANG L, Qi Y, Xiong Y, Peng Z, et al
    Ezrin-Radixin-Moesin Binding Phosphoprotein 50 (EBP50) Suppresses the Metastasis of Breast Cancer and HeLa Cells by Inhibiting Matrix Metalloproteinase-2 Activity.
    Anticancer Res. 2017;37:4353-4360.
    PubMed     Text format     Abstract available


  43. LIANG G, Liu Z, Tan L, Su AN, et al
    HIF1alpha-associated circDENND4C Promotes Proliferation of Breast Cancer Cells in Hypoxic Environment.
    Anticancer Res. 2017;37:4337-4343.
    PubMed     Text format     Abstract available


  44. LIU Z, Liang G, Tan L, Su AN, et al
    High-efficient Screening Method for Identification of Key Genes in Breast Cancer Through Microarray and Bioinformatics.
    Anticancer Res. 2017;37:4329-4335.
    PubMed     Text format     Abstract available


  45. UHERCIK M, Sanders AJ, Owen S, Davies EL, et al
    Clinical Significance of PD1 and PDL1 in Human Breast Cancer.
    Anticancer Res. 2017;37:4249-4254.
    PubMed     Text format     Abstract available


  46. KLAPKO O, Ghoulam E, Jakate S, Eswaran S, et al
    Anastrozole-induced Autoimmune Hepatitis: A Rare Complication of Breast Cancer Therapy.
    Anticancer Res. 2017;37:4173-4176.
    PubMed     Text format     Abstract available


  47. CARBONNELLE D, Luu TH, Chaillou C, Huvelin JM, et al
    LXR Activation Down-regulates Lipid Raft Markers FLOT2 and DHHC5 in MCF-7 Breast Cancer Cells.
    Anticancer Res. 2017;37:4067-4073.
    PubMed     Text format     Abstract available


  48. SOBKOWICZ AD, Sanders AJ, Mason MD, Jiang WG, et al
    Potential Implication of Paxillin in Cancer Establishment Within the Bone Environment.
    Anticancer Res. 2017;37:4255-4268.
    PubMed     Text format     Abstract available


    July 2017
  49. REMO M, Abraham I, Kankanala V, Chacra W, et al
    Hepatitis B Reactivation in a Patient Receiving Chemotherapy for Breast Cancer: A Case Report.
    Anticancer Res. 2017;37:3791-3793.
    PubMed     Text format     Abstract available


  50. MESCHER C, Ding C, Defor T, Konety S, et al
    Left Ventricular Ejection Fraction Screening and Clinical Decision-making in Metastatic HER2-positive Breast Cancer.
    Anticancer Res. 2017;37:3751-3755.
    PubMed     Text format     Abstract available


  51. CHIRICO A, D'Aiuto G, Penon A, Mallia L, et al
    Self-Efficacy for Coping with Cancer Enhances the Effect of Reiki Treatments During the Pre-Surgery Phase of Breast Cancer Patients.
    Anticancer Res. 2017;37:3657-3665.
    PubMed     Text format     Abstract available


  52. ORFANIDOU T, Xanthopoulos K, Dafou D, Pseftogas A, et al
    Down-regulation of the Tumor Suppressor CYLD Enhances the Transformed Phenotype of Human Breast Cancer Cells.
    Anticancer Res. 2017;37:3493-3503.
    PubMed     Text format     Abstract available


  53. ALCANTARA DZ, Soliman IJS, Pobre RF, Naguib RNG, et al
    Effects of Pulsed Electromagnetic Fields on Breast Cancer Cell Line MCF 7 Using Absorption Spectroscopy.
    Anticancer Res. 2017;37:3453-3459.
    PubMed     Text format     Abstract available


  54. HU T, Su F, Jiang W, Dart DA, et al
    Overexpression of Activin Receptor-like Kinase 7 in Breast Cancer Cells Is Associated with Decreased Cell Growth and Adhesion.
    Anticancer Res. 2017;37:3441-3451.
    PubMed     Text format     Abstract available


  55. KOBAYASHI H, Hamasaki M, Morishita T, Inoue T, et al
    Analysis of Evolving Clinicopathological Features of Metastatic Brain Tumors Over 30 Years of Surgical Management.
    Anticancer Res. 2017;37:3969-3974.
    PubMed     Text format     Abstract available


  56. KONDO H, Shimono Y, Mukohyama J, Tanaka Y, et al
    Discordance of MCM7 mRNA and its Intronic MicroRNA Levels Under Hypoxia.
    Anticancer Res. 2017;37:3885-3890.
    PubMed     Text format     Abstract available


  57. MADEKIVI V, Bostrom P, Aaltonen R, Vahlberg T, et al
    The Sentinel Node with Isolated Breast Tumor Cells or Micrometastases. Benefits and Risks of Axillary Dissection.
    Anticancer Res. 2017;37:3757-3762.
    PubMed     Text format     Abstract available


  58. MARIAMPILLAI AI, Cruz JPD, Suh J, Sivapiragasam A, et al
    Cancer Antigen 72-4 for the Monitoring of Advanced Tumors of the Gastrointestinal Tract, Lung, Breast and Ovaries.
    Anticancer Res. 2017;37:3649-3656.
    PubMed     Text format     Abstract available


    June 2017
  59. FURRER D, Jacob S, Caron C, Sanschagrin F, et al
    Concordance of HER2 Immunohistochemistry and Fluorescence In Situ Hybridization Using Tissue Microarray in Breast Cancer.
    Anticancer Res. 2017;37:3323-3329.
    PubMed     Text format     Abstract available


  60. STAMPFLI SF, Akhmedov A, Hausladen S, Varga Z, et al
    Tissue Factor Expression Does Not Predict Mortality in Breast Cancer Patients.
    Anticancer Res. 2017;37:3259-3264.
    PubMed     Text format     Abstract available


  61. BANYS-PALUCHOWSKI M, Witzel I, Riethdorf S, Rack B, et al
    Clinical Relevance of Serum HER2 and Circulating Tumor Cell Detection in Metastatic Breast Cancer Patients.
    Anticancer Res. 2017;37:3117-3128.
    PubMed     Text format     Abstract available


  62. GAVRESSEA T, Kalogeras KT, Koliou GA, Zagouri F, et al
    The Prognostic Value of the Immunohistochemical Expression of Phosphorylated RB and p16 Proteins in Association with Cyclin D1 and the p53 Pathway in a Large Cohort of Patients with Breast Cancer Treated with Taxane-based Adjuvant Chemotherapy.
    Anticancer Res. 2017;37:2947-2957.
    PubMed     Text format     Abstract available


  63. CHRISTOPOULOS PF, Papageorgiou E, Petraki C, Koutsilieris M, et al
    The COOH-terminus of the IGF-1Ec Isoform Enhances the Proliferation and Migration of Human MCF-7 Breast Cancer Cells.
    Anticancer Res. 2017;37:2899-2912.
    PubMed     Text format     Abstract available


  64. KUBAN-JANKOWSKA A, Gorska-Ponikowska M, Wozniak M
    Lipoic Acid Decreases the Viability of Breast Cancer Cells and Activity of PTP1B and SHP2.
    Anticancer Res. 2017;37:2893-2898.
    PubMed     Text format     Abstract available


  65. NEUHAUSEN SL, Shani H, Boker LK, Steele L, et al
    Primary Peritoneal Serous Carcinoma in Men: A Rare and Non-BRCA-associated Entity.
    Anticancer Res. 2017;37:3069-3072.
    PubMed     Text format     Abstract available


    May 2017
  66. BYSTRICKY B, Cierna Z, Sieberova G, Janega P, et al
    Relationship Between Circulating Tumor Cells and Annexin A2 in Early Breast Cancer Patients.
    Anticancer Res. 2017;37:2727-2734.
    PubMed     Text format     Abstract available


  67. ESKELINEN M, Selander T, Ollonen P, Korhonen R, et al
    Moderate/severe Depression (MADRS) Can Affect the Quality of Life and Outcome Among Patients Admitted to Breast Cancer Diagnosis Unit.
    Anticancer Res. 2017;37:2641-2647.
    PubMed     Text format     Abstract available


  68. ANGELINI S, Botticelli A, Onesti CE, Giusti R, et al
    Pharmacogenetic Approach to Toxicity in Breast Cancer Patients Treated with Taxanes.
    Anticancer Res. 2017;37:2633-2639.
    PubMed     Text format     Abstract available


  69. MIYATA M, Ohguri T, Yahara K, Yamaguchi S, et al
    Salvage Radiotherapy for Solitary Metachronous Bone Metastasis in Patients with Breast Cancer.
    Anticancer Res. 2017;37:2575-2579.
    PubMed     Text format     Abstract available


  70. KHAN GN, Kim EJ, Shin TS, Lee SH, et al
    Azacytidine-induced Chemosensitivity to Doxorubicin in Human Breast Cancer MCF7 Cells.
    Anticancer Res. 2017;37:2355-2364.
    PubMed     Text format     Abstract available


  71. STRATI TM, Kotoula V, Kostopoulos I, Manousou K, et al
    Prognostic Subcellular Notch2, Notch3 and Jagged1 Localization Patterns in Early Triple-negative Breast Cancer.
    Anticancer Res. 2017;37:2323-2334.
    PubMed     Text format     Abstract available


  72. JIANG XP, Elliott RL
    Decreased Iron in Cancer Cells and Their Microenvironment Improves Cytolysis of Breast Cancer Cells by Natural Killer Cells.
    Anticancer Res. 2017;37:2297-2305.
    PubMed     Text format     Abstract available


  73. DA CRUZ PAULA A, Lopes C
    Implications of Different Cancer Stem Cell Phenotypes in Breast Cancer.
    Anticancer Res. 2017;37:2173-2183.
    PubMed     Text format     Abstract available


    April 2017
  74. THANGARAJAH F, Enninga I, Malter W, Hamacher S, et al
    A Retrospective Analysis of Ki-67 Index and its Prognostic Significance in Over 800 Primary Breast Cancer Cases.
    Anticancer Res. 2017;37:1957-1964.
    PubMed     Text format     Abstract available


  75. INOUE Y, Yamashita N, Tokunaga E, Tanaka K, et al
    A Locally Advanced Breast Cancer that Achieved pCR with Pertuzumab, Trastuzumab and Docetaxel: Case Report.
    Anticancer Res. 2017;37:1917-1921.
    PubMed     Text format     Abstract available


  76. OKU Y, Nishiya N, Tsuda K, Shibazaki M, et al
    Dynamic Phenotypic Transition of Breast Cancer Cells In Vitro Revealed by Self-floating Cell Culture.
    Anticancer Res. 2017;37:1793-1797.
    PubMed     Text format     Abstract available


  77. BYSTRICKY B, Jurisova S, Karaba M, Minarik G, et al
    Relationship Between Circulating Tumor Cells and Tissue Plasminogen Activator in Patients with Early Breast Cancer.
    Anticancer Res. 2017;37:1787-1791.
    PubMed     Text format     Abstract available


  78. KIM KY, Park KI, Kim SH, Yu SN, et al
    Salinomycin Induces Reactive Oxygen Species and Apoptosis in Aggressive Breast Cancer Cells as Mediated with Regulation of Autophagy.
    Anticancer Res. 2017;37:1747-1758.
    PubMed     Text format     Abstract available


  79. DAS T, Nair RR, Green R, Padhee S, et al
    Actinomycin D Down-regulates SOX2 Expression and Induces Death in Breast Cancer Stem Cells.
    Anticancer Res. 2017;37:1655-1663.
    PubMed     Text format     Abstract available


  80. ACUNA UM, Curley RW Jr, Fatima N, Ahmed S, et al
    Differential Effect of Wortmannolone Derivatives on MDA-MB-231 Breast Cancer Cells.
    Anticancer Res. 2017;37:1617-1623.
    PubMed     Text format     Abstract available


  81. JELINEK M, Kabelova A, Sramek J, Seitz J, et al
    Differing Mechanisms of Death Induction by Fluorinated Taxane SB-T-12854 in Breast Cancer Cells.
    Anticancer Res. 2017;37:1581-1590.
    PubMed     Text format     Abstract available


  82. CHIRICO A, Serpentini S, Merluzzi T, Mallia L, et al
    Self-efficacy for Coping Moderates the Effects of Distress on Quality of Life in Palliative Cancer Care.
    Anticancer Res. 2017;37:1609-1615.
    PubMed     Text format     Abstract available


  83. KAISER CG, Herold M, Krammer J, Baltzer P, et al
    Prognostic Value of "Prepectoral Edema" in MR-mammography.
    Anticancer Res. 2017;37:1989-1995.
    PubMed     Text format     Abstract available


  84. VOGL UM, Ohler L, Rasic M, Frischer JM, et al
    Evaluation of Prognostic Immune Signatures in Patients with Breast, Colorectal and Pancreatic Cancer Receiving Chemotherapy.
    Anticancer Res. 2017;37:1947-1955.
    PubMed     Text format     Abstract available


    March 2017
  85. KIM HA, Kim JH, Choi HS, Kim YG, et al
    Core Needle Biopsy Specimens Are More Appropriate than Surgical Specimens for Evaluating the Expression of Phosphoproteins as Biological Markers in Invasive Breast Cancer.
    Anticancer Res. 2017;37:1409-1412.
    PubMed     Text format     Abstract available


  86. DIERAS V, Pop S, Berger F, Dujaric ME, et al
    First-line Bevacizumab and Paclitaxel for HER2-negative Metastatic Breast Cancer: A French Retrospective Observational Study.
    Anticancer Res. 2017;37:1403-1407.
    PubMed     Text format     Abstract available


  87. WENDT C, Lindblom A, Arver B, VON Wachenfeldt A, et al
    Parent of Origin and Prognosis in Familial Breast Cancer in Sweden.
    Anticancer Res. 2017;37:1257-1262.
    PubMed     Text format     Abstract available


  88. MACK N, Mazzio EA, Bauer D, Flores-Rozas H, et al
    Stable shRNA Silencing of Lactate Dehydrogenase A (LDHA) in Human MDA-MB-231 Breast Cancer Cells Fails to Alter Lactic Acid Production, Glycolytic Activity, ATP or Survival.
    Anticancer Res. 2017;37:1205-1212.
    PubMed     Text format     Abstract available


  89. WINDRICHOVA J, Fuchsova R, Kucera R, Topolcan O, et al
    MIC1/GDF15 as a Bone Metastatic Disease Biomarker.
    Anticancer Res. 2017;37:1501-1505.
    PubMed     Text format     Abstract available


  90. SEKIDO Y, Ohigashi S, Takahashi T, Hayashi N, et al
    Familial Gastrointestinal Stromal Tumor with Germline KIT Mutations Accompanying Hereditary Breast and Ovarian Cancer Syndrome.
    Anticancer Res. 2017;37:1425-1431.
    PubMed     Text format     Abstract available


  91. IIZUKA D, Sasatani M, Barcellos-Hoff MH, Kamiya K, et al
    Hydrogen Peroxide Enhances TGFbeta-mediated Epithelial-to-Mesenchymal Transition in Human Mammary Epithelial MCF-10A Cells.
    Anticancer Res. 2017;37:987-995.
    PubMed     Text format     Abstract available


    February 2017
  92. ILENKO A, Sergent F, Mercuzot A, Zitoun M, et al
    Could Patients Older than 75 Years Benefit from a Systematic Breast Cancer Screening Program?
    Anticancer Res. 2017;37:903-907.
    PubMed     Text format     Abstract available


  93. LAWLER G, Leech M
    Dose Sparing Potential of Deep Inspiration Breath-hold Technique for Left Breast Cancer Radiotherapy Organs-at-risk.
    Anticancer Res. 2017;37:883-890.
    PubMed     Text format     Abstract available


  94. ESKELINEN M, Korhonen R, Selander T, Ollonen P, et al
    Beck Depression Inventory as a Predictor of Long-term Outcome Among Patients Admitted to the Breast Cancer Diagnosis Unit: A 25-year Cohort Study in Finland.
    Anticancer Res. 2017;37:819-824.
    PubMed     Text format     Abstract available


  95. WU HC, Southey MC, Hibshoosh H, Santella RM, et al
    DNA Methylation in Breast Tumor from High-risk Women in the Breast Cancer Family Registry.
    Anticancer Res. 2017;37:659-664.
    PubMed     Text format     Abstract available


  96. ONISHI H, Suyama K, Yamasaki A, Oyama Y, et al
    CD24 Modulates Chemosensitivity of MCF-7 Breast Cancer Cells.
    Anticancer Res. 2017;37:561-565.
    PubMed     Text format     Abstract available


    January 2017

  97. Radiation Therapy Techniques and Treatment Planning for Breast Cancer.
    Anticancer Res. 2017;37:369-370.
    PubMed     Text format    



  98. The Pathobiology of Breast Cancer.
    Anticancer Res. 2017;37:365.
    PubMed     Text format    


  99. YANG X, DU G, Yu Z, Si Y, et al
    A Novel NHERF1 Mutation in Human Breast Cancer and Effects on Malignant Progression.
    Anticancer Res. 2017;37:67-73.
    PubMed     Text format     Abstract available


  100. YANO S, Takehara K, Kishimoto H, Tazawa H, et al
    Comparison of Tumor Recurrence After Resection of Highly- and Poorly-Metastatic Triple-negative Breast Cancer in Orthotopic Nude-Mouse Models.
    Anticancer Res. 2017;37:57-60.
    PubMed     Text format     Abstract available


  101. DAMASKOS C, Valsami S, Kontos M, Spartalis E, et al
    Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer.
    Anticancer Res. 2017;37:35-46.
    PubMed     Text format     Abstract available


  102. STRIEN L, Joensuu K, Heikkila P, Leidenius MH, et al
    Different Expression Patterns of CXCR4, CCR7, Maspin and FOXP3 in Luminal Breast Cancers and Their Sentinel Node Metastases.
    Anticancer Res. 2017;37:175-182.
    PubMed     Text format     Abstract available


  103. GIPPONI M, Baldelli I, Atzori G, Fregatti P, et al
    Tumescent Anesthesia in Skin- and Nipple-sparing Mastectomy: Results of a Prospective Clinical Study.
    Anticancer Res. 2017;37:349-352.
    PubMed     Text format     Abstract available


  104. SCHRODER L, Koch J, Mahner S, Kost BP, et al
    The Effects of Petroselinum Crispum on Estrogen Receptor-positive Benign and Malignant Mammary Cells (MCF12A/MCF7).
    Anticancer Res. 2017;37:95-102.
    PubMed     Text format     Abstract available


    December 2016
  105. RAY A, Khong B, Khong HT
    A Case Report of Pneumocystis Jiroveci Pneumonia in a Patient with Metastatic Breast Cancer.
    Anticancer Res. 2016;36:6673-6676.
    PubMed     Text format     Abstract available


  106. LUKESOVA L, Vrana D, Svach I, Zlamalova N, et al
    Prognostic Influence of Internal Mammary Node Drainage in Patients with Early-stage Breast Cancer.
    Anticancer Res. 2016;36:6641-6646.
    PubMed     Text format     Abstract available


  107. SAKAGUCHI K, Nakatsukasa K, Taguchi T
    Phase I Study of Triweekly Nab-Paclitaxel Combined with S-1 in Patients with HER2-negative Metastatic Breast Cancer.
    Anticancer Res. 2016;36:6515-6519.
    PubMed     Text format     Abstract available


  108. TANAKA S, Iwamoto M, Kimura K, Takahashi Y, et al
    A Phase II Study of Adjuvant Chemotherapy of Tegafur-Uracil for Patients with Breast Cancer with HER2-negative Pathologic Residual Invasive Disease After Neoadjuvant Chemotherapy.
    Anticancer Res. 2016;36:6505-6509.
    PubMed     Text format     Abstract available


  109. TIAINEN L, Tanner M, Lahdenpera O, Vihinen P, et al
    Bevacizumab Combined with Docetaxel or Paclitaxel as First-line Treatment of HER2-negative Metastatic Breast Cancer.
    Anticancer Res. 2016;36:6431-6438.
    PubMed     Text format     Abstract available


  110. RAMDANI LH, Talhi O, Taibi N, Delort L, et al
    Effects of Spiro-bisheterocycles on Proliferation and Apoptosis in Human Breast Cancer Cell Lines.
    Anticancer Res. 2016;36:6399-6408.
    PubMed     Text format     Abstract available


  111. LEE J, Jung JH, Chae YS, Park HY, et al
    Long Noncoding RNA snaR Regulates Proliferation, Migration and Invasion of Triple-negative Breast Cancer Cells.
    Anticancer Res. 2016;36:6289-6295.
    PubMed     Text format     Abstract available


  112. YANO S, Takehara K, Kishimoto H, Tazawa H, et al
    In Vivo Selection of Intermediately- and Highly-Malignant Variants of Triple-negative Breast Cancer in Orthotopic Nude Mouse Models.
    Anticancer Res. 2016;36:6273-6277.
    PubMed     Text format     Abstract available


    November 2016
  113. SHINDEN Y, Kijima Y, Hirata M, Arima H, et al
    Clinical Significance of the Histoculture Drug Response Assay in Breast Cancer.
    Anticancer Res. 2016;36:6173-6178.
    PubMed     Text format     Abstract available


  114. LEE SJ, Park BN, Roh JH, An YS, et al
    Enhancing the Therapeutic Efficacy of 2-Deoxyglucose in Breast Cancer Cells Using Cell-cycle Synchronization.
    Anticancer Res. 2016;36:5975-5980.
    PubMed     Text format     Abstract available


  115. PIRES BR, DE Amorim IS, Souza LD, Rodrigues JA, et al
    Targeting Cellular Signaling Pathways in Breast Cancer Stem Cells and its Implication for Cancer Treatment.
    Anticancer Res. 2016;36:5681-5691.
    PubMed     Text format     Abstract available


  116. VOUTSADAKIS IA
    Immune Blockade Inhibition in Breast Cancer.
    Anticancer Res. 2016;36:5607-5622.
    PubMed     Text format     Abstract available


    October 2016
  117. WALDREP AR, Avery EJ, Rose FF Jr, Midathada MV, et al
    Breast Cancer Subtype Influences the Accuracy of Predicting Pathologic Response by Imaging and Clinical Breast Exam After Neoadjuvant Chemotherapy.
    Anticancer Res. 2016;36:5389-5395.
    PubMed     Text format     Abstract available


  118. QIN W, Holick MF, Sorensen W, Walker CR, et al
    Vitamin D3 Treatment Influences PGE2 and TGFbeta in Normal and Increased Breast Cancer Risk Women.
    Anticancer Res. 2016;36:5347-5353.
    PubMed     Text format     Abstract available


  119. VILSMAIER T, Rack B, Konig A, Friese K, et al
    Influence of Circulating Tumour Cells on Production of IL-1alpha, IL-1beta and IL-12 in Sera of Patients with Primary Diagnosis of Breast Cancer Before Treatment.
    Anticancer Res. 2016;36:5227-5236.
    PubMed     Text format     Abstract available


  120. TAKEDA S, Okazaki H, Kudo T, Kakizoe K, et al
    Bongkrekic Acid as a Warburg Effect Modulator in Long-term Estradiol-deprived MCF-7 Breast Cancer Cells.
    Anticancer Res. 2016;36:5171-5182.
    PubMed     Text format     Abstract available


  121. GANGAPURAM M, Jean R, Mazzio E, Badisa R, et al
    Substituted Tetrahydroisoquinolines as Microtubule-destabilizing Agents in Triple Negative Human Breast Cancer Cells.
    Anticancer Res. 2016;36:5043-5052.
    PubMed     Text format     Abstract available


  122. SHAVERDIAN N, Wang J, Levin-Epstein R, Schaue D, et al
    Pro-inflammatory State Portends Poor Outcomes with Stereotactic Radiosurgery for Brain Metastases.
    Anticancer Res. 2016;36:5333-5337.
    PubMed     Text format     Abstract available


  123. STAHL JM, Hong JC, Lester-Coll NH, Kann BH, et al
    Chest Wall Deformity in the Radiation Oncology Clinic.
    Anticancer Res. 2016;36:5295-5300.
    PubMed     Text format     Abstract available


  124. FUJII T, Yajima R, Kurozumi S, Higuchi T, et al
    Clinical Significance of 18F-FDG-PET in Invasive Lobular Carcinoma.
    Anticancer Res. 2016;36:5481-5485.
    PubMed     Text format     Abstract available


    September 2016
  125. RIOS N, Adaskina N, Fromke C, Papendorf F, et al
    The Benefit of Baseline Staging-Risk Assessment of Distant Breast Cancer Metastases by Tumor Stage.
    Anticancer Res. 2016;36:4909-14.
    PubMed     Text format     Abstract available


  126. KIM YJ, Kim K, Lee R, Kim J, et al
    Two-year Follow-up of Volumetric-modulated Arc Therapy for Treating Internal Mammary Nodes in Locally Advanced Breast Cancer.
    Anticancer Res. 2016;36:4847-51.
    PubMed     Text format     Abstract available


  127. HEPP P, Andergassen U, Jager B, Trapp E, et al
    Association of CA27.29 and Circulating Tumor Cells Before and at Different Times After Adjuvant Chemotherapy in Patients with Early-stage Breast Cancer - The SUCCESS Trial.
    Anticancer Res. 2016;36:4771-6.
    PubMed     Text format     Abstract available


  128. FURRER D, Jacob S, Caron C, Sanschagrin F, et al
    Tissue Microarray Is a Reliable Tool for the Evaluation of HER2 Amplification in Breast Cancer.
    Anticancer Res. 2016;36:4661-6.
    PubMed     Text format     Abstract available


  129. WAZIR U, El Hage Chehade H, Headon H, Oteifa M, et al
    Oncological Safety of Lipofilling in Patients with Breast Cancer: A Meta-analysis and Update on Clinical Practice.
    Anticancer Res. 2016;36:4521-8.
    PubMed     Text format     Abstract available


  130. KAPPIL M, Terry MB, Delgado-Cruzata L, Liao Y, et al
    Mismatch Repair Polymorphisms as Markers of Breast Cancer Prevalence in the Breast Cancer Family Registry.
    Anticancer Res. 2016;36:4437-41.
    PubMed     Text format     Abstract available


  131. DO SI, Yoon G, Kim HS, Kim K, et al
    Increased Brahma-related Gene 1 Expression Predicts Distant Metastasis and Shorter Survival in Patients with Invasive Ductal Carcinoma of the Breast.
    Anticancer Res. 2016;36:4873-82.
    PubMed     Text format     Abstract available


    August 2016

  132. Handbook of HER2-Targeted Agents in Breast Cancer.
    Anticancer Res. 2016;36:4377.
    PubMed     Text format    


  133. KARLIKOVA M, Topolcan O, Narsanska A, Kucera R, et al
    Circulating Growth and Angiogenic Factors and Lymph Node Status in Early-stage Breast Cancer - A Pilot Study.
    Anticancer Res. 2016;36:4209-14.
    PubMed     Text format     Abstract available


  134. PIMENTEL C, Becquet M, Lavoue V, Henno S, et al
    Ovarian Metastases from Breast Cancer: A Series of 28 Cases.
    Anticancer Res. 2016;36:4195-200.
    PubMed     Text format     Abstract available


  135. KAPPIL MA, Liao Y, Terry MB, Santella RM, et al
    DNA Repair Gene Expression Levels as Indicators of Breast Cancer in the Breast Cancer Family Registry.
    Anticancer Res. 2016;36:4039-44.
    PubMed     Text format     Abstract available


  136. CHIANG KC, Hsu SY, Lin SJ, Yeh CN, et al
    PTEN Insufficiency Increases Breast Cancer Cell Metastasis In Vitro and In Vivo in a Xenograft Zebrafish Model.
    Anticancer Res. 2016;36:3997-4005.
    PubMed     Text format     Abstract available


  137. FULAWKA L, Halon A
    Proliferation Index Evaluation in Breast Cancer Using ImageJ and ImmunoRatio Applications.
    Anticancer Res. 2016;36:3965-72.
    PubMed     Text format     Abstract available


  138. HOWARD CB, McDowell R, Feleke K, Deer E, et al
    Chemotherapeutic Vulnerability of Triple-negative Breast Cancer Cell-derived Tumors to Pretreatment with Vernonia amygdalina Aqueous Extracts.
    Anticancer Res. 2016;36:3933-43.
    PubMed     Text format     Abstract available


  139. BENDRAT K, Fritz P, Muller S, Brockmoller S, et al
    Improved Risk Stratification for Breast Cancer Samples Based on the Expression Ratio of the Estrogen and Progesterone Receptor.
    Anticancer Res. 2016;36:3855-63.
    PubMed     Text format     Abstract available


  140. YANO S, Takehara K, Miwa S, Kishimoto H, et al
    In Vivo Isolation of a Highly-aggressive Variant of Triple-negative Human Breast Cancer MDA-MB-231 Using Serial Orthotopic Transplantation.
    Anticancer Res. 2016;36:3817-20.
    PubMed     Text format     Abstract available



  141. Breast Disease. Management and Therapies.
    Anticancer Res. 2016;36:4376.
    PubMed     Text format    


  142. LUCZYNSKA E, Heinze S, Adamczyk A, Rys J, et al
    Comparison of the Mammography, Contrast-Enhanced Spectral Mammography and Ultrasonography in a Group of 116 patients.
    Anticancer Res. 2016;36:4359-66.
    PubMed     Text format     Abstract available


  143. FUJII T, Yajima R, Kuwano H
    Implications of Long-term Indwelling of Tissue Expander in Breast Reconstruction: Risk of Expander Rupturing.
    Anticancer Res. 2016;36:4337-40.
    PubMed     Text format     Abstract available


    July 2016
  144. NAM SO, Yotsumoto F, Miyata K, Fukagawa S, et al
    Anti-tumor Effect of Intravenous Administration of CRM197 for Triple-negative Breast Cancer Therapy.
    Anticancer Res. 2016;36:3651-7.
    PubMed     Text format     Abstract available


  145. SHIMAMURA Y, Tamatani D, Kuniyasu S, Mizuki Y, et al
    5-Aminolevulinic Acid Enhances Ultrasound-mediated Antitumor Activity via Mitochondrial Oxidative Damage in Breast Cancer.
    Anticancer Res. 2016;36:3607-12.
    PubMed     Text format     Abstract available


  146. CRISCITIELLO C, Bagnardi V, Viale G, Disalvatore D, et al
    HER2 Equivocal Status in Early Breast Cancer Is Not Associated with Higher Risk of Recurrence.
    Anticancer Res. 2016;36:3537-40.
    PubMed     Text format     Abstract available


  147. SU CH, Lane HY, Hsiao CL, Liu LC, et al
    Matrix Metalloproteinase-1 Genetic Polymorphism in Breast Cancer in Taiwanese.
    Anticancer Res. 2016;36:3341-3345.
    PubMed     Text format     Abstract available


  148. SAMARA P, Skopeliti M, Tsiatas ML, Georgaki S, et al
    A Cytokine Cocktail Augments the Efficacy of Adoptive NK-92 Cell Therapy Against Mouse Xenografts of Human Cancer.
    Anticancer Res. 2016;36:3373-82.
    PubMed     Text format     Abstract available


    June 2016

  149. Novel Biomarkers in the Continuum of Breast Cancer.
    Anticancer Res. 2016;36:3224.
    PubMed     Text format    


  150. ANDERGASSEN U, Vogl A, Mumm JN, Kolbl AC, et al
    Immunocytochemical Characterization of Disseminated Tumour Cells from Bone Marrow of Breast Cancer Patients.
    Anticancer Res. 2016;36:3217-22.
    PubMed     Text format     Abstract available


  151. KOLBL AC, Brauer D, Hutter S, Rack B, et al
    New Marker Genes for Real-Time PCR-based Detection of Circulating Tumour Cells from Blood of Breast Cancer Patients.
    Anticancer Res. 2016;36:3211-6.
    PubMed     Text format     Abstract available


  152. KOLBEN T, Hary T, Holdt LM, Schwarz TM, et al
    Thyroid Hormones and Vitamin D in Patients with Breast Cancer with Mutations in BRCA1 or BRCA2 Genes.
    Anticancer Res. 2016;36:3185-90.
    PubMed     Text format     Abstract available


  153. FREIER CP, Kuhn C, Endres S, Mayr D, et al
    FOXP3+ Cells Recruited by CCL22 into Breast Cancer Correlates with Less Tumor Nodal Infiltration.
    Anticancer Res. 2016;36:3139-45.
    PubMed     Text format     Abstract available


  154. KONIG A, Vilsmaier T, Rack B, Friese K, et al
    Determination of Interleukin-4, -5, -6, -8 and -13 in Serum of Patients with Breast Cancer Before Treatment and its Correlation to Circulating Tumor Cells.
    Anticancer Res. 2016;36:3123-30.
    PubMed     Text format     Abstract available


  155. FUJII T, Yajima R, Tsuboi M, Higuchi T, et al
    Clinicopathological Features of Cases with Primary Breast Cancer not Identified by 18F-FDG-PET.
    Anticancer Res. 2016;36:3019-22.
    PubMed     Text format     Abstract available


  156. SHIMA H, Kutomi G, Satomi F, Maeda H, et al
    SOX2 and ALDH1 as Predictors of Operable Breast Cancer.
    Anticancer Res. 2016;36:2945-53.
    PubMed     Text format     Abstract available


  157. BRAUTIGAM K, Mitzlaff K, Uebel L, Koster F, et al
    Subtypes of Triple-negative Breast Cancer Cell Lines React Differently to Eribulin Mesylate.
    Anticancer Res. 2016;36:2759-66.
    PubMed     Text format     Abstract available


  158. SCHELZ Z, Ocsovszki I, Bozsity N, Hohmann J, et al
    Antiproliferative Effects of Various Furanoacridones Isolated from Ruta graveolens on Human Breast Cancer Cell Lines.
    Anticancer Res. 2016;36:2751-8.
    PubMed     Text format     Abstract available


  159. KASSAYOVA M, Bobrov N, Strojny L, Orendas P, et al
    Anticancer and Immunomodulatory Effects of Lactobacillus plantarum LS/07, Inulin and Melatonin in NMU-induced Rat Model of Breast Cancer.
    Anticancer Res. 2016;36:2719-28.
    PubMed     Text format     Abstract available


  160. KIM JY, Heo SH, Song IH, Park IA, et al
    Activation of the PERK-eIF2alpha Pathway Is Associated with Tumor-infiltrating Lymphocytes in HER2-Positive Breast Cancer.
    Anticancer Res. 2016;36:2705-11.
    PubMed     Text format     Abstract available


  161. MIN DJ, He S, Green JE
    Birinapant (TL32711) Improves Responses to GEM/AZD7762 Combination Therapy in Triple-negative Breast Cancer Cell Lines.
    Anticancer Res. 2016;36:2649-57.
    PubMed     Text format     Abstract available


    April 2016
  162. WINDRICHOVA J, Fuchsova R, Kucera R, Topolcan O, et al
    Testing of a Novel Cancer Metastatic Multiplex Panel for the Detection of Bone-metastatic Disease - a Pilot Study.
    Anticancer Res. 2016;36:1973-8.
    PubMed     Text format     Abstract available


  163. RAPOSO TP, Beirao BC, Pires I, Prada J, et al
    Immunohistochemical Expression of CCR2, CSF1R and MMP9 in Canine Inflammatory Mammary Carcinomas.
    Anticancer Res. 2016;36:1805-13.
    PubMed     Text format     Abstract available


  164. MOSS T, Chirico A, Mallia L, Lucidi F, et al
    Psychosocial Outcomes of Quadrantectomy Versus Mastectomy in a Southern Italian Sample: Development and Needs of the Italian Derriford Appearance Scale 24.
    Anticancer Res. 2016;36:1519-26.
    PubMed     Text format     Abstract available


    March 2016
  165. CUI YX, Evans BA, Jiang WG
    New Roles of Osteocytes in Proliferation, Migration and Invasion of Breast and Prostate Cancer Cells.
    Anticancer Res. 2016;36:1193-201.
    PubMed     Text format     Abstract available


    February 2016
  166. AMABILE MI, Monti M, Merola R, Frusone F, et al
    Nipple-sparing Mastectomy in Patients with Preoperative Diagnosis of Non-invasive Breast Carcinoma. A Single-center Experience.
    Anticancer Res. 2016;36:779-83.
    PubMed     Text format     Abstract available


  167. KUCERA R, Topolcan O, Fiala O, Kinkorova J, et al
    The Role of TPS and TPA in the Diagnostics of Distant Metastases.
    Anticancer Res. 2016;36:773-7.
    PubMed     Text format     Abstract available


    January 2016
  168. GITT A, Bose-Ribeiro H, Nieder C, Kup PG, et al
    Treatment Results of MammoSite Catheter in Combination with Whole-breast Irradiation.
    Anticancer Res. 2016;36:355-60.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: